0001104659-21-091356.txt : 20210712
0001104659-21-091356.hdr.sgml : 20210712
20210712205859
ACCESSION NUMBER: 0001104659-21-091356
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210625
FILED AS OF DATE: 20210712
DATE AS OF CHANGE: 20210712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Horsager Alan M
CENTRAL INDEX KEY: 0001871699
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39788
FILM NUMBER: 211086606
MAIL ADDRESS:
STREET 1: 1021 N EVERETT STREET
CITY: GLENDALE
STATE: CA
ZIP: 91207
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Scopus BioPharma Inc.
CENTRAL INDEX KEY: 0001772028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821248020
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
BUSINESS PHONE: (212) 479-2513
MAIL ADDRESS:
STREET 1: 420 LEXINGTON AVENUE, SUITE 300
CITY: NEW YORK
STATE: NY
ZIP: 10170
FORMER COMPANY:
FORMER CONFORMED NAME: Scopus Biopharma Inc.
DATE OF NAME CHANGE: 20190327
3
1
tm2122052d2_3.xml
OWNERSHIP DOCUMENT
X0206
3
2021-06-25
0
0001772028
Scopus BioPharma Inc.
SCPS
0001871699
Horsager Alan M
C/O SCOPUS BIOPHARMA, INC.,
420 LEXINGTON AVENUE, SUITE 300
NY
NY
10170
0
1
0
0
See Remarks
Common Stock
118200
D
President and CEO of Olimmune (100% Subsidiary)
/s/ Alan M. Horsager, Ph.D
2021-07-12